{{Rsnum
|rsid=11902236
|Gene=GRHL1
|Chromosome=2
|position=9977740
|Orientation=plus
|GMAF=0.3044
|Gene_s=GRHL1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 46.0 | 43.4 | 10.6
| HCB | 73.7 | 24.8 | 1.5
| JPT | 90.2 | 8.9 | 0.9
| YRI | 12.9 | 47.6 | 39.5
| ASW | 14.0 | 63.2 | 22.8
| CHB | 73.7 | 24.8 | 1.5
| CHD | 78.7 | 18.5 | 2.8
| GIH | 69.7 | 24.2 | 6.1
| LWK | 10.4 | 50.0 | 39.6
| MEX | 59.6 | 35.1 | 5.3
| MKK | 9.3 | 51.7 | 39.1
| TSI | 39.6 | 50.5 | 9.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23535732
  |Trait=Prostate cancer
  |Title=Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
  |RiskAllele=A
  |Pval=3E-8
  |OR=1.07
  |ORtxt=[1.03-1.10]
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}